← FDA Drug Approvals (Drugs@FDA)

SERPASIL

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1954-08-13

Drug application

FDA Application #

NDA009434

Application type

New Drug Application

Brand name

SERPASIL

Generic name

Reserpine

Active ingredients

RESERPINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1954-08-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown